Strategies for Evading Cellular Immunity Against Recombinant AAV Vectors in Gene Therapy

Current Medical Science · Published 2026-03-30 · DOI 10.1007/s11596-026-00178-9

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s11596-026-00178-9

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Peptide Loading Complex in Cancer: From Peptide Translocation, Editing, and Loading into MHC-I to a Potential Therapeutic Target · Current Medical Science · 2026 · Same journal
• METTL3–m6A–LOXL2 Axis Post-Transcriptionally Fine-Tunes Macrophage Migration and Invasion · Current Medical Science · 2026 · Same journal
• Overcoming the Viscosity-Strength Trade-Off in 3D-Printable Dental Resins by Hydrogen Bond Engineering · Current Medical Science · 2026 · Same journal
• Predictive Value of Admission Renal Injury-Related Indicators for Fatal Outcomes in Patients with Severe Fever with Thrombocytopenia Syndrome · Current Medical Science · 2026 · Same journal
• Integrated DNA Repair Capacity and NER Gene Expression for Improving Risk Prediction in Head and Neck Squamous Cell Carcinoma · Current Medical Science · 2026 · Same journal
• Pain Medicine Specialist: Championing High-Quality Development for Neuromodulation Technology · Current Medical Science · 2026 · Same journal
• Trehalose: A Promising Therapeutic Agent for Diverse Pathological Conditions · Current Medical Science · 2026 · Same journal
• Advances and Clinical Applications of Thrombopoietic Agents · Current Medical Science · 2026 · Same journal
• Bone Morphogenetic Proteins in Obesity Management: Therapeutic Potential and Challenges Beyond the Skeleton · Current Medical Science · 2026 · Same journal
• Matrix Competence Failure in Osteoporosis: Mechanosensing, Osteoimmune Crosstalk, and Fragility Beyond Bone Mineral Density · Current Medical Science · 2026 · Same journal